The focus of obesity-management interventions should shift from percentage weight-loss targets to patient-oriented parameters such as enhancing quality of life (QoL) and function, research to be ...
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one ...
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback